Indago Seeks to Reduce O.R. Inefficiencies with ArthroFree Arthroscopic Camera System
The company has developed a number of fundamental technologies to eliminate the cables that are currently endemic to endoscopic procedures.
Industry Voices
Medacta CEO Confident in Orthopedics’ Fundamentals
Mr. Francesco Siccardi opens up about market opportunities, headwinds and strategies for Medacta while dealing with the COVID-19 outbreak.
COVID-19 is a Disruption Accelerator. Are You Prepared?
Tiger Buford talks about changes to technology and the roles of product development and sales and marketing post-COVID-19.
Retiring Bioventus CEO Shares Thoughts on Orthobiologics Market
Mr. Bihl feels that orthobiologics are in a unique position to address unmet needs that remain prevalent despite advancements in traditional orthopedic products.
Studies Shed Light on Late-Onset Infection
While the spine industry has focused on 3D printed cages, enabling technology and minimally invasive surgery, it has forgotten a critical priority: infection prevention, says Aakash Agarwal, Ph.D., Director of Research at Spinal Balance.
What is the Future of Orthopedic Innovation? Lessons from HSS
In moving to the provider side of orthopedics after spending decades in industry, Doug Leach has learned a valuable lesson: Partner with providers. Not just the surgeon.
Mathys CEO Talks People, Technology in Joint Replacement
Benjamin Reinmann, M.D., says that the joint replacement market is moving away from the implant toward services driven by technology and keeping value-based patient care on the radar.
Utilization Management “New Normal” Means Challenges with Prior Authorizations and Appeals
Spine surgery faces utilization management challenges that are influencing patients' access to care and surgeons' abilities to navigate the current payor environment. Device companies can better serve surgeons and their patients by remaining abreast of changes to the payor climate.
Spinal Kinetics Founder Shares Keys to Startup Success
Many of the lessons that Tom Afzal has applied throughout his career he learned while working at American Hospital Supply Corporation—one of the largest medical device companies in the ‘70s-‘80s—his first professional position after college. As part of a management path program, Mr. Afzal was required to work in many functional areas of the company—sales, marketing, finance, production, R&D, quality, etc.
Startup Spotlight: Carmell Therapeutics Takes Regenerative Medicine to the Next Level with Controlled Degradable Biologic
For years, orthobiologics and other forms of regenerative medicine have sought to mimic and enhance the body's natural ability to heal itself. Carmell Therapeutics has a new approach to that end-goal. The company's proprietary process is designed to bind and cross-link regenerative factors in lyophilized platelet-enriched plasma into solid and semi-solid plasma-based materials to accelerate healing in bone, tendon and wound care.